Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Shang Min Zhang"'
Autor:
Qin Yan, Marcus W. Bosenberg, Daniel P. Kelly, Matthew D. Hall, Anton Simeonov, Stephen C. Kales, Daniel J. Jansen, Ling Lai, Irina Krykbaeva, Meaghan K. McGeary, Shang-Min Zhang, Xiaoni Liu
Tumor heterogeneity is a major challenge for cancer treatment, especially due to the presence of various subpopulations with stem cell or progenitor cell properties. In mouse melanomas, both CD34+p75− (CD34+) and CD34−p75− (CD34−) tumor subpo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::067c56d0d5b3eb34e6f9c5b1dfc605d1
https://doi.org/10.1158/1535-7163.c.6538539.v1
https://doi.org/10.1158/1535-7163.c.6538539.v1
Autor:
Qin Yan, Marcus W. Bosenberg, Daniel P. Kelly, Matthew D. Hall, Anton Simeonov, Stephen C. Kales, Daniel J. Jansen, Ling Lai, Irina Krykbaeva, Meaghan K. McGeary, Shang-Min Zhang, Xiaoni Liu
Figure S1. Responses of different YUMM cell lines to BRAFi treatment; Figure S2. Inhibition of KDM5 family members by shRNA knockdown and pan-KDM5 inhibitors; Figure S3. Subpopulation composition in tumors of different volumes; Figure S4. In vivo BRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29b44f79f8fe1852f77e511980e40fd
https://doi.org/10.1158/1535-7163.22506975
https://doi.org/10.1158/1535-7163.22506975
Data from KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis
Autor:
Zhenbang Chen, Qin Yan, Robert J. Matusik, Samuel E. Adunyah, Xinchun Zhou, Billy R. Ballard, Tao Lu, Qi Liu, Michael G. Izban, Sherly I. Celada, Shang-Min Zhang, Mike R. Zou, Wenfu Lu, Thanigaivelan Kanagasabai, Guoliang Li
KDM5B (lysine[K]-specific demethylase 5B) is frequently upregulated in various human cancers including prostate cancer. KDM5B controls H3K4me3/2 levels and regulates gene transcription and cell differentiation, yet the contributions of KDM5B to prost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f92281df5c765f7787c588440bdc38a7
https://doi.org/10.1158/0008-5472.c.6512665.v1
https://doi.org/10.1158/0008-5472.c.6512665.v1
Autor:
Zhenbang Chen, Qin Yan, Robert J. Matusik, Samuel E. Adunyah, Xinchun Zhou, Billy R. Ballard, Tao Lu, Qi Liu, Michael G. Izban, Sherly I. Celada, Shang-Min Zhang, Mike R. Zou, Wenfu Lu, Thanigaivelan Kanagasabai, Guoliang Li
Suppl Figs S1-S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a230d28533f4eb86eedf0e632abebf6
https://doi.org/10.1158/0008-5472.22427422
https://doi.org/10.1158/0008-5472.22427422
Autor:
Zhenbang Chen, Qin Yan, Robert J. Matusik, Samuel E. Adunyah, Xinchun Zhou, Billy R. Ballard, Tao Lu, Qi Liu, Michael G. Izban, Sherly I. Celada, Shang-Min Zhang, Mike R. Zou, Wenfu Lu, Thanigaivelan Kanagasabai, Guoliang Li
Table S1, S2 and S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23587c4cd28345225e4b483936192783
https://doi.org/10.1158/0008-5472.22427419.v1
https://doi.org/10.1158/0008-5472.22427419.v1
Autor:
Shlomit Jessel, Wesley L. Cai, Xiaoni Liu, Kim Blenman, Carmen J. Booth, Marcus Bosenberg, Goran Micevic, Shang-Min Zhang, Yangyi Zhang, William Damsky, Harriet M. Kluger, Meaghan K. McGeary, Qin Yan, Jiesi Luo, Eric Song, Akiko Iwasaki, Durga Thakral, Mario Sznol, Mingzhu Yin, Lok Hei Chan, Lucia B. Jilaveanu
Publikováno v:
Nature. 598:682-687
Tumours use various strategies to evade immune surveillance1,2. Immunotherapies targeting tumour immune evasion such as immune checkpoint blockade have shown considerable efficacy on multiple cancers3,4 but are ineffective for most patients due to pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c935e3b9c47ac6de523df0827385669c
https://doi.org/10.1038/s41586-021-03994-2
https://doi.org/10.1038/s41586-021-03994-2
Autor:
Christopher W. Anderson, Yifan Yuan, Juan Wang, Mehmet H. Kural, Yuyao Lin, Jiesi Luo, Xiangyu Shi, Matthew W. Ellis, Yibing Qyang, Muhammad Riaz, Laura E. Niklason, Shang-Min Zhang
Publikováno v:
Acta Biomater
Tissue engineered vascular grafts (TEVGs) represent a promising therapeutic option for emergency vascular intervention. Although the application of small-diameter TEVGs using patient-specific primary endothelial cells (ECs) to prevent thrombosis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dc36ef695f9a47138f8218c395cfaa0
https://doi.org/10.1016/j.actbio.2020.11.007
https://doi.org/10.1016/j.actbio.2020.11.007
Publikováno v:
Stem Cells and Development. 28:1288-1298
Induced pluripotent stem cell (iPSC) technology offers a practically infinite and ethically acceptable source to obtain a variety of somatic cells. Coupled with the biotechnologies of cell therapy or tissue engineering, iPSC technology will enormousl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b18aa37a3ec9ede6438c1c510c62253
https://doi.org/10.1089/scd.2019.0136
https://doi.org/10.1089/scd.2019.0136
Autor:
Irina Krykbaeva, Shang-Min Zhang, Stephen C. Kales, Daniel J. Jansen, Meaghan K. McGeary, Matthew D. Hall, Ling Lai, Xiaoni Liu, Anton Simeonov, Qin Yan, Daniel P. Kelly, Marcus Bosenberg
Publikováno v:
Molecular Cancer Therapeutics. 18:706-717
Tumor heterogeneity is a major challenge for cancer treatment, especially due to the presence of various subpopulations with stem cell or progenitor cell properties. In mouse melanomas, both CD34+p75− (CD34+) and CD34−p75− (CD34−) tumor subpo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad613cb2e202ff11c6758a11e30835d
https://doi.org/10.1158/1535-7163.mct-18-0395
https://doi.org/10.1158/1535-7163.mct-18-0395
Publikováno v:
Stem cell reviews and reports. 17(3)
Tissue engineered vascular grafts (TEVGs) generated from human primary cells represent a promising vascular interventional therapy. However, generation and application of these TEVGs may be significantly hindered by the limited accessibility, finite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1419b1ef45bb2b8d5aac4dbb76ca1115
https://pubmed.ncbi.nlm.nih.gov/33230612
https://pubmed.ncbi.nlm.nih.gov/33230612